Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.49%Stock Based Compensation Margin
VS
Market
Sector
Industry
History
$ 9.16Close
$ 4.26 - $ 11.97 52-Week Range
Ticker Information
Ticker
EBSCompany Name
EMERGENT BIOSOLUTIONS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NYSEEMERGENT BIOSOLUTIONS INC - Stock Based Compensation Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
EBS - SB Comp % Historical data
| Date | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
|---|---|---|---|
| 6/30/2025 | $ 851.6M | $ 12.7M | 1.49% |
| 3/31/2025 | $ 965.4M | $ 13.6M | 1.41% |
| 12/31/2024 | $ 1.04B | $ 18M | 1.72% |
| 9/30/2024 | $ 1.13B | $ 17.7M | 1.57% |
| 6/30/2024 | $ 1.1B | $ 19.4M | 1.76% |
| 3/31/2024 | $ 1.19B | $ 22.2M | 1.87% |
| 12/31/2023 | $ 1.05B | $ 23.1M | 2.2% |
| 9/30/2023 | $ 1.1B | $ 30.8M | 2.79% |
| 6/30/2023 | $ 1.07B | $ 38M | 3.54% |
| 3/31/2023 | $ 978.5M | $ 42M | 4.29% |
Key Performance Insights, Last 5 Years
- EMERGENT BIOSOLUTIONS INC's latest trailing twelve months (TTM) SB Comp % stands at 3.5%.
- Over the past 5 years, EMERGENT BIOSOLUTIONS INC's average SB Comp % has been 2.6%.
- The median SB Comp % for EMERGENT BIOSOLUTIONS INC during this period was 2.51%
- EMERGENT BIOSOLUTIONS INC reached its highest SB Comp % over the past 5 years at 4.29%.
- The lowest SB Comp % recorded by EMERGENT BIOSOLUTIONS INC in the same timeframe 1.41%
EMERGENT BIOSOLUTIONS INC's SB Comp % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp % Benchmarks
Similar metrics to SB Comp %:
- Stock Based Compensation - [Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
Definition of Stock Based Compensation Margin
[Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].SB Comp. / Revenues
(=) SB Comp % SB Comp % for EMERGENT BIOSOLUTIONS INC is calculated as follows: SB Comp. [ $ 46.7M ] / Revenues [ $ 1.33B ]
(=) SB Comp % [ 3.5% ] EBS - Stock Based Compensation Margin, Last 5 years
1.41%
Minimum
Mar 31, 2025
4.29%
Maximum
Mar 31, 2023
2.6%
Average
2.51%
Median
SB Comp % Benchmark AnalysisMarket
The chart above depicts the distribution of SB Comp % for companies in the Total Stock Market. The average SB Comp % of the companies is 1.72% with a standard deviation of 1.9%.
The following table provides additional summary stats:
SB Comp % in the Market:
| filtered constituents | 2.99K |
|---|---|
| min | -3.97% |
| max | 8.43% |
| average | 1.72% |
| median | 1.04% |
| std | 1.9% |